Myrexis Competitors and Similar CompaniesClear all

Myrexis's competitors and similar companies include Merrimack Pharmaceuticals and Oncopeptides.

	Myrexis Myrexis (formerly known as Myriad Pharmaceuticals) is a molecular biopharmaceutical company.	Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.	Oncopeptides Oncopeptides is a clinical development pharmaceutical company.
Founding Date	Founding Date 1999	Founding Date 2000	Founding Date 2000
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations New York, US HQ	Locations Cambridge, US HQ	Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US
Employees	Employees N/A	Employees 2763% decrease	Employees 80
Valuation ($)	Valuation ($) 4.1 m	Valuation ($) 223.7 m	Valuation ($) 42.4 m
Financial
Net income	Net income N/A	Net income ($1.2m) (FY, 2023)	Net income (kr249.6m) (FY, 2025)

For sources of this data, please see the company profile

Cambridge, US

Employees

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

Stockholm, SE

Employees

Oncopeptides is a clinical development pharmaceutical company.

Financial